Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News
  • Published:

Report disputes benefit of stockpiling Tamiflu

Medical panel suggests bulk purchase of influenza drug was a waste of money, but others caution against dropping anti-pandemic strategy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Jefferson, T. et al. Br. Med. J. 339, b5106 (2009).

    Article  Google Scholar 

  2. Jefferson, T. et al. Cochrane Database of Systematic Reviews CD008965 (2014).

  3. Kaiser, L. et al. Arch. Intern. Med. 163, 1667-1672 (2003).

    Article  CAS  Google Scholar 

  4. Hsu, J. et al. Ann. Intern. Med. 3, 512-524 (2012).

    Article  Google Scholar 

  5. Muthuri, S. et al. Lancet Respir. Med. http://dx.doi.org/10.1016/S2213-2600(14)70041-4 (2014).

Download references

Authors

Related links

Related links

Related links in Nature Research

Secrets of trial data revealed 2013-Oct-08

Drug-company data vaults to be opened 2013-Mar-27

Avian flu special: What's in the medicine cabinet? 2005-May-25

Related external links

The British Medical Journal and Cochrane Collaboration's Tamiflu campaign

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Noorden, R. Report disputes benefit of stockpiling Tamiflu. Nature (2014). https://doi.org/10.1038/nature.2014.15022

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nature.2014.15022

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research